BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 29, 2020
View Archived Issues
Oral drug can wake up telomerase
Read More
Older siblings' example turns stem cells into heart cells
Read More
Preclinical evaluation of the survivin inhibitor FL-118 in relapsed/refractory multiple myeloma
Read More
KCNMB1 methylation increases BK channel activity, resulting in myofibroblast differentiation in IPF
Read More
Human recombinant ACE2 blocks the early stages of SARS-CoV-2 infection in cell and tissue models
Read More
First patient dosed in proof-of-concept of OTL-201 gene therapy
Read More
Phase III VOYAGER study of avapritinib does not meet primary endpoint
Read More
Tetra Bio-Pharma to develop PPP-003 for management of CRS
Read More
Topline data from phase III study of Dextenza in allergic conjunctivitis
Read More
Vicore receives regulatory approval to initiate phase II study of VP-01 in COVID-19
Read More
FDA clears IND application for CRX-100
Read More
Regenacy Pharmaceuticals discloses new HDAC1/HDAC2 inhibitors
Read More
ABBV-951 shows promising safety in patients with Parkinson's disease
Read More
Protein binder specific for hPD-1 shows strong antitumor activity in vivo
Read More
First prospective peek at Thrive's Cancerseek reveals gaps in liquid biopsy testing
Read More
Interim phase I data for ATOR-1015 presented by Alligator Bioscience
Read More
New thyroid hormone receptor beta agonists synthesized at Inventisbio Shanghai
Read More
FORMA Therapeutics describes new FAS inhibitors
Read More
New glucocorticoid receptor antagonists discovered at ORIC Pharmaceuticals
Read More
Sage Therapeutics patents GABA(A) receptor modulators
Read More
Innate's avdoralimab studied in phase II trial for patients with COVID-19 and severe pneumonia
Read More
Phase II interim results presented for GX-188E + pembrolizumab in HPV-positive cervical cancer
Read More